jkr pharma ltd

Live YoungSmallDeclining

jkr pharma ltd Company Information

Share JKR PHARMA LTD

Company Number

10255643

Shareholders

tusharbhai harshad patel

a2z pharmacy limited

Group Structure

View All

Industry

Other human health activities

 

Registered Address

5 high road, london, N22 6BH

Website

-

jkr pharma ltd Estimated Valuation

£691.4k

Pomanda estimates the enterprise value of JKR PHARMA LTD at £691.4k based on a Turnover of £1.2m and 0.57x industry multiple (adjusted for size and gross margin).

jkr pharma ltd Estimated Valuation

£836.9k

Pomanda estimates the enterprise value of JKR PHARMA LTD at £836.9k based on an EBITDA of £193.3k and a 4.33x industry multiple (adjusted for size and gross margin).

jkr pharma ltd Estimated Valuation

£289.4k

Pomanda estimates the enterprise value of JKR PHARMA LTD at £289.4k based on Net Assets of £116.1k and 2.49x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Jkr Pharma Ltd Overview

Jkr Pharma Ltd is a live company located in london, N22 6BH with a Companies House number of 10255643. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2016, it's largest shareholder is tusharbhai harshad patel with a 54.5% stake. Jkr Pharma Ltd is a young, small sized company, Pomanda has estimated its turnover at £1.2m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Jkr Pharma Ltd Health Check

Pomanda's financial health check has awarded Jkr Pharma Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

4 Strong

positive_score

2 Regular

positive_score

6 Weak

size

Size

annual sales of £1.2m, make it larger than the average company (£730.1k)

£1.2m - Jkr Pharma Ltd

£730.1k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -16%, show it is growing at a slower rate (7.2%)

-16% - Jkr Pharma Ltd

7.2% - Industry AVG

production

Production

with a gross margin of 38.3%, this company has a comparable cost of product (38.3%)

38.3% - Jkr Pharma Ltd

38.3% - Industry AVG

profitability

Profitability

an operating margin of 9.7% make it more profitable than the average company (5.1%)

9.7% - Jkr Pharma Ltd

5.1% - Industry AVG

employees

Employees

with 8 employees, this is below the industry average (19)

8 - Jkr Pharma Ltd

19 - Industry AVG

paystructure

Pay Structure

on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)

£26.5k - Jkr Pharma Ltd

£26.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £151.8k, this is more efficient (£45.5k)

£151.8k - Jkr Pharma Ltd

£45.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 32 days, this is later than average (20 days)

32 days - Jkr Pharma Ltd

20 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 83 days, this is slower than average (18 days)

83 days - Jkr Pharma Ltd

18 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 66 days, this is more than average (13 days)

66 days - Jkr Pharma Ltd

13 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 8 weeks, this is less cash available to meet short term requirements (127 weeks)

8 weeks - Jkr Pharma Ltd

127 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 93.8%, this is a higher level of debt than the average (22%)

93.8% - Jkr Pharma Ltd

22% - Industry AVG

JKR PHARMA LTD financials

EXPORTms excel logo

Jkr Pharma Ltd's latest turnover from March 2024 is estimated at £1.2 million and the company has net assets of £116.1 thousand. According to their latest financial statements, Jkr Pharma Ltd has 8 employees and maintains cash reserves of £91.1 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Turnover1,214,7361,289,7881,472,3272,065,9262,121,4302,100,2881,770,0110
Other Income Or Grants00000000
Cost Of Sales749,032806,226937,6611,359,0701,357,1351,368,0291,118,3250
Gross Profit465,703483,562534,665706,856764,294732,259651,6860
Admin Expenses347,595315,041384,486598,437612,265624,116605,3460
Operating Profit118,108168,521150,179108,419152,029108,14346,3400
Interest Payable156,141138,16588,30084,19288,319102,63850,7090
Interest Receivable4,6193,4433561933218340
Pre-Tax Profit-33,41433,79962,23524,24663,7435,723-4,3350
Tax0-6,422-11,825-4,607-12,111-1,08700
Profit After Tax-33,41427,37750,41019,63951,6324,636-4,3350
Dividends Paid00000000
Retained Profit-33,41427,37750,41019,63951,6324,636-4,3350
Employee Costs211,966250,749262,546254,692249,361289,369171,8100
Number Of Employees8101111111380
EBITDA*193,266240,951208,229166,469210,079194,71867,9840

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Tangible Assets162,970181,0787501,7502,7503,7504,7500
Intangible Assets1,354,9421,411,9921,469,0431,526,0931,583,1431,604,5371,690,1120
Investments & Other00000000
Debtors (Due After 1 year)00000000
Total Fixed Assets1,517,9121,593,0701,469,7931,527,8431,585,8931,608,2871,694,8620
Stock & work in progress136,890135,750132,230150,365168,650169,500167,2500
Trade Debtors106,746111,570124,026196,190194,435177,112166,8120
Group Debtors00000000
Misc Debtors29,19262,33033,12449,78839,63238,44837,925110
Cash91,05484,89277,13017,87520,58344,60513,5500
misc current assets00000000
total current assets363,882394,542366,510414,218423,300429,665385,537110
total assets1,881,7941,987,6121,836,3031,942,0612,009,1932,037,9522,080,399110
Bank overdraft149,220149,220100,65524,15996,91996,34894,6800
Bank loan00068,4210000
Trade Creditors 171,645208,119215,760248,937323,507352,257330,7390
Group/Directors Accounts215,000197,000187,000187,000187,000187,000187,0000
other short term finances00000000
hp & lease commitments00000000
other current liabilities28,3767,80140,66588,87431,81517,4226,6180
total current liabilities564,241562,140544,080617,391639,241653,027619,0370
loans1,201,4481,275,9531,170,0811,252,9881,317,9091,384,5141,465,5870
hp & lease commitments00000000
Accruals and Deferred Income00000000
other liabilities00000000
provisions00000000
total long term liabilities1,201,4481,275,9531,170,0811,252,9881,317,9091,384,5141,465,5870
total liabilities1,765,6891,838,0931,714,1611,870,3791,957,1502,037,5412,084,6240
net assets116,105149,519122,14271,68252,043411-4,225110
total shareholders funds116,105149,519122,14271,68252,043411-4,225110
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Operating Activities
Operating Profit118,108168,521150,179108,419152,029108,14346,3400
Depreciation18,10815,3791,0001,0001,0001,0002500
Amortisation57,05057,05157,05057,05057,05085,57521,3940
Tax0-6,422-11,825-4,607-12,111-1,08700
Stock1,1403,520-18,135-18,285-8502,250167,2500
Debtors-37,96216,750-88,82811,91118,50710,823204,627110
Creditors-36,474-7,641-33,177-74,570-28,75021,518330,7390
Accruals and Deferred Income20,575-32,864-48,20957,05914,39310,8046,6180
Deferred Taxes & Provisions00000000
Cash flow from operations214,189173,754221,981150,725165,954212,88033,464-110
Investing Activities
capital expenditure0-195,70700-35,6560-1,716,5060
Change in Investments00000000
cash flow from investments0-195,70700-35,6560-1,716,5060
Financing Activities
Bank loans00-68,42168,4210000
Group/Directors Accounts18,00010,0000000187,0000
Other Short Term Loans 00000000
Long term loans-74,505105,872-82,907-64,921-66,605-81,0731,465,5870
Hire Purchase and Lease Commitments00000000
other long term liabilities00000000
share issue00500000110
interest-151,522-134,722-87,944-84,173-88,286-102,420-50,6750
cash flow from financing-208,027-18,850-239,222-80,673-154,891-183,4931,601,912110
cash and cash equivalents
cash6,1627,76259,255-2,708-24,02231,05513,5500
overdraft048,56576,496-72,7605711,66894,6800
change in cash6,162-40,803-17,24170,052-24,59329,387-81,1300

jkr pharma ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for jkr pharma ltd. Get real-time insights into jkr pharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Jkr Pharma Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for jkr pharma ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in N22 area or any other competitors across 12 key performance metrics.

jkr pharma ltd Ownership

JKR PHARMA LTD group structure

Jkr Pharma Ltd has no subsidiary companies.

Ultimate parent company

JKR PHARMA LTD

10255643

JKR PHARMA LTD Shareholders

tusharbhai harshad patel 54.55%
a2z pharmacy limited 45.45%

jkr pharma ltd directors

Jkr Pharma Ltd currently has 3 directors. The longest serving directors include Tusharbhai Patel (Jun 2016) and Mr Vikash Patel (Jun 2016).

officercountryagestartendrole
Tusharbhai PatelUnited Kingdom48 years Jun 2016- Director
Mr Vikash PatelUnited Kingdom45 years Jun 2016- Director
Mr Samir Gokal47 years Jun 2016- Director

P&L

March 2024

turnover

1.2m

-6%

operating profit

118.1k

0%

gross margin

38.4%

+2.26%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

116.1k

-0.22%

total assets

1.9m

-0.05%

cash

91.1k

+0.07%

net assets

Total assets minus all liabilities

jkr pharma ltd company details

company number

10255643

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

June 2016

age

9

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

March 2023

previous names

N/A

accountant

-

auditor

-

address

5 high road, london, N22 6BH

Bank

-

Legal Advisor

-

jkr pharma ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to jkr pharma ltd.

jkr pharma ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for JKR PHARMA LTD. This can take several minutes, an email will notify you when this has completed.

jkr pharma ltd Companies House Filings - See Documents

datedescriptionview/download